Kronox Lab Sciences IPO Details
IPO Date	June 3, 2024 to June 5, 2024
Listing Date	June 10, 2024
Face Value	₹10 per share
Issue Price Band	₹129 to ₹136 per share
Issue Price Final	₹136 per share
Lot Size	110 Shares
Sale Type	Offer For Sale
Total Issue Size	95,70,000 shares
(aggregating up to ₹130.15 Cr)
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Share Holding Pre Issue	3,71,04,000 shares
Share Holding Post Issue	3,71,04,000 shares
Kronox Lab Sciences IPO Reservation
Kronox Lab Sciences IPO offers total 95,70,000 shares. Out of which 47,85,000 (50.00%) allocated to QIB, 19,14,000 (20.00%) allocated to QIB, 14,35,500 (15.00%) allocated to NII, 33,49,500 (35.00%) allocated to RII and 28,71,000 (30.00%) allocated to Anchor investors.

Investor Category	Shares Offered	Maximum Allottees
QIB Shares Offered	47,85,000 (50.00%)	NA
NII (HNI) Shares Offered	14,35,500 (15.00%)	NA
Retail Shares Offered	33,49,500 (35.00%)	30,450
Total Shares Offered	95,70,000 (100.00%)	
Kronox Lab Sciences IPO Anchor Investors Details
Kronox Lab Sciences IPO raises ₹39.05 crore from anchor investors. Kronox Lab Sciences IPO Anchor bid date is May 31, 2024. Kronox Lab Sciences IPO Anchor Investors list

Bid Date	May 31, 2024
Shares Offered	28,71,000
Anchor Portion Size (In Cr.)	39.05
Anchor lock-in period end date for 50% shares (30 Days)	July 6, 2024
Anchor lock-in period end date for remaining shares (90 Days)	September 4, 2024
Kronox Lab Sciences IPO Timeline (Tentative Schedule)
Kronox Lab Sciences IPO opens on June 3, 2024, and closes on June 5, 2024.

IPO Open Date	Mon, Jun 3, 2024
IPO Close Date	Wed, Jun 5, 2024
Tentative Allotment	Thu, Jun 6, 2024
Initiation of Refunds	Fri, Jun 7, 2024
Credit of Shares to Demat	Fri, Jun 7, 2024
Tentative Listing Date	Mon, Jun 10, 2024
Cut-off time for UPI mandate confirmation	5 PM on Wed, Jun 5, 2024
Kronox Lab Sciences IPO Lot Size
Investors can bid for a minimum of 110 shares and in multiples thereof.  The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	110	₹14,960
Retail (Max)	13	1,430	₹1,94,480
S-HNI (Min)	14	1,540	₹2,09,440
S-HNI (Max)	66	7,260	₹9,87,360
B-HNI (Min)	67	7,370	₹10,02,320
Kronox Lab Sciences IPO Promoter Holding
The Promoters of the Company are Jogindersingh Jaswal, Ketan Ramani and Pritesh Ramani.
Promoter Holding Pre Issue	99.98%
Promoter Holding Post Issue	74.21%
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue

About Kronox Lab Sciences Ltd.
Incorporated in 2008, Kronox Lab Sciences Limited is a manufacturer of high-purity speciality fine chemicals for diverse end-user industries. The company's High Purity Specialty Fine Chemicals are used in various applications such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products.

The company offers a wide range of over 185 products, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, and others. These products are supplied to customers in India and more than 20 countries worldwide.

The company exports its products to countries such as United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, United Kingdom, Belgium, United Arab Emirates, China, among others.

The company has three manufacturing facilities in Vadodara, Gujarat, close to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. The facilities cover 17,454 sq. m. and have an installed capacity of 7,242 TPA as of December 31, 2023. Unit I/II holds FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications. Additionally, some products manufactured at Unit I have obtained Kosher, Halal, GMP, and GLP certifications.

As of December 31, 2023, the company is conducting research and development on 122 products.

The company has served over 592 customers in the past three years. By December 31, 2023, 141 customers of the total, placed repeat orders.

As of December 31, 2023, the company employees 212 people at various levels.

Company Financials
Kronox Lab Sciences Limited Financial Information (Restated)
Kronox Lab Sciences Limited's revenue increased by 16.99% and profit after tax (PAT) rose by 21.94% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Dec 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	66.96	54.03	56.79	37.65
Total Income	68.44	97.50	83.34	63.24
Profit After Tax	15.47	16.62	13.63	9.73
Net Worth	60.28	44.68	40.35	26.81
Reserves and Surplus	15.56	7.58	40.11	26.57
Total Borrowing			0.64	0.01
Amount in ₹ Crore
Key Performance Indicator (KPI)
The market capitalization of Kronox Lab Sciences IPO is ₹504.61 Cr.

KPI as of Sun, Dec 31, 2023.

KPI	Values
ROE	25.66%
ROCE	33.15%
RoNW	25.66%
PAT Margin	22.60%
Price to Book Value	8.37
Check Kronox Lab Sciences IPO Peer Comparison here.
Pre IPO	Post IPO
EPS Rs	4.48	5.56
P/E (x)	30.37	24.47
Note:
The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2023 that is available in RHP.
The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of December 31, 2023 that is available in RHP.
Objects of the Issue (Kronox Lab Sciences IPO Objectives)
The Objects of the Offer are to:

Carry out the Offer for Sale of up to 95,70,000 Equity Shares by the Promoter Selling Shareholders; and
Achieve the benefits of listing the Equity Shares on the Stock Exchanges. Further, the Company expects that the proposed listing of the Equity Shares will enhance the visibility and brand image, provide liquidity to its existing Shareholders, and provide a public market for Equity Shares in India.
Kronox Lab Sciences IPO Review
[Dilip Davda]  The company is in high-purity speciality chemical segment and enjoys virtual monopoly in certain products. Its product portfolio currently has 185 products and another 122 is in the pipeline. Based on FY24 annualized earnings, the issue appears fully priced. Investors may park funds for the medium to long term rewards. Read detail review...

Kronox Lab Sciences IPO Subscription Status (Bidding Detail)
The Kronox Lab Sciences IPO is subscribed 117.25 times on June 5, 2024 6:19:05 PM (Day 3). The public issue subscribed 54.24 times in the retail category, 89.03 times in the QIB category, and 301.92 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category	Subscription (times)	Shares Offered	Shares bid for
QIB	89.03	19,14,000	17,04,09,360
NII	301.92	14,35,500	43,34,02,530
    bNII (bids above ₹10L)	322.26	9,57,000	30,84,06,670
    sNII (bids below ₹10L)	261.22	4,78,500	12,49,95,860
Retail	54.24	33,49,500	18,16,61,810
Total	117.25	66,99,000	78,54,73,700
Total Application : 15,28,029

Kronox Lab Sciences IPO Prospectus
  ›  Kronox Lab Sciences IPO DRHP
  ›  Kronox Lab Sciences IPO RHP
  ›  Anchor Investors in Kronox Lab Sciences IPO
  ›  Kronox Lab Sciences IPO Final Prospectus
Kronox Lab Sciences IPO Listing Details
Listing Date	June 10, 2024
BSE Script Code	544187
NSE Symbol	KRONOX
ISIN	INE0ATZ01017
Final Issue Price	₹136 per share
BSE Listing Group	T (Trade to Trade)
Pre-Open Session - NSEPre-Open Session - BSE

Listing Day Trading Information
Price Details	NSE SME	NSE SME
Final Issue Price	₹136.00	₹136.00
Open	₹151.40	₹151.35
Low	₹151.40	₹151.35
High	₹156.20	₹158.20
Last Trade	₹151.40	₹151.35